This analysis utilized a multivariable logistic regression model to evaluate factors influencing the reporting of ocular toxicity events in breast cancer patients, considering age, type of CDK4/6 inhibitor, number of concomitant medications, and whether letrozole was used concomitantly. Here, CDK4 is linked to breast carcinoma.